Autolus Therapeutics plc
AUTL
$2.03
-$0.08-3.79%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -39.11M | -71.60M | -90.33M | -79.12M | -47.92M |
| Total Depreciation and Amortization | 2.65M | 2.70M | 2.63M | 2.54M | 2.37M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.49M | 20.09M | 19.40M | 21.03M | -4.31M |
| Change in Net Operating Assets | 6.91M | -16.50M | 983.00K | -12.35M | -22.92M |
| Cash from Operations | -25.07M | -65.32M | -67.32M | -67.90M | -72.78M |
| Capital Expenditure | -913.00K | -2.69M | 885.00K | -4.41M | -7.28M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 68.81M | 98.84M | 85.66M | 39.96M | 103.19M |
| Cash from Investing | 67.90M | 96.15M | 86.54M | 35.55M | 95.92M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.00K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.14M | -2.06M | -1.80M | -1.77M | -768.00K |
| Cash from Financing | -2.14M | -2.06M | -1.80M | -1.77M | -768.00K |
| Foreign Exchange rate Adjustments | -199.00K | -1.99M | 589.00K | -3.58M | 5.72M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 40.49M | 26.78M | 18.01M | -37.71M | 28.08M |